
    
      Within the 12 months of the study procedure, the 3rd month is what we called the "check
      point". At this point, participants' plasma LDL-C will be measured whether it reached
      individual standard or not. If the results didn't meet the particular LDL-C standard, the
      participants would be adjusted the drug dosage (pitavastatin 4mg/day, atorvastatin 40mg/day).
    
  